QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa)
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative proctitis
- Focus Therapeutic Use
- Acronyms QUARTZ
- Sponsors Ferring Pharmaceuticals
- 03 Jul 2018 Status changed from active, no longer recruiting to completed.
- 10 Apr 2018 Planned End Date changed from 31 Mar 2018 to 31 May 2018.
- 06 Mar 2018 Planned End Date changed from 1 Feb 2018 to 31 Mar 2018.